| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Biotin | NBP1-28406 | |||
| FITC | NBP1-28405 | |||
| PE | NBP1-28407 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-22190-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB110-96873-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB110-96887-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-12904-0.025mg | |||
![Flow Cytometry: CD28 Antibody (CD28.2) [NBP1-79126] - Surface staining pattern of human peripheral blood stained using anti-human CD28 (CD28.2) purified antibody (concentration in sample 1,6 ug/ml) GAM APC.](http://images.novusbio.com/fullsize/CD28-Antibody-CD28-2-Flow-Cytometry-NBP1-79126-img0009.jpg "Flow Cytometry: CD28 Antibody (CD28.2) [NBP1-79126] - Surface staining pattern of human peripheral blood stained using anti-human CD28 (CD28.2) purified antibody (concentration in sample 1,6 ug/ml) GAM APC.")
![Flow Cytometry: CD28 Antibody (CD28.2) [NBP1-79126] - Surface staining of human peripheral blood leukocytes with anti-human CD28 (CD28.2) purified.](http://images.novusbio.com/fullsize/CD28-Antibody-CD28-2-Flow-Cytometry-NBP1-79126-img0001.jpg)
![Flow Cytometry: CD28 Antibody (CD28.2) [NBP1-79126] - Surface staining of human peripheral blood leukocytes with anti-human CD28 (CD28.2) PE.](http://images.novusbio.com/fullsize/CD28-Antibody-CD28-2-Flow-Cytometry-NBP1-79126-img0002.jpg)
![Flow Cytometry: CD28 Antibody (CD28.2) [NBP1-79126] - Surface staining of human peripheral blood leukocytes with anti-human CD28 (CD28.2) PerCP-CyTM5.5](http://images.novusbio.com/fullsize/CD28-Antibody-CD28-2-Flow-Cytometry-NBP1-79126-img0003.jpg)
![Flow Cytometry: CD28 Antibody (CD28.2) [NBP1-79126] - Surface staining of human peripheral blood leukocytes with anti-human CD28 (CD28.2) APC.](http://images.novusbio.com/fullsize/CD28-Antibody-CD28-2-Flow-Cytometry-NBP1-79126-img0004.jpg)
![Flow Cytometry: CD28 Antibody (CD28.2) [NBP1-79126] - Surface staining of human peripheral blood leukocytes with anti-human CD28 (CD28.2) PerCP.](http://images.novusbio.com/fullsize/CD28-Antibody-CD28-2-Flow-Cytometry-NBP1-79126-img0005.jpg)
![Flow Cytometry: CD28 Antibody (CD28.2) [NBP1-79126] - Surface staining of human peripheral blood leukocytes with anti-human CD28 (CD28.2) FITC.](http://images.novusbio.com/fullsize/CD28-Antibody-CD28-2-Flow-Cytometry-NBP1-79126-img0006.jpg)
![Flow Cytometry: CD28 Antibody (CD28.2) [NBP1-79126] - Surface staining of human peripheral blood leukocytes with anti-human CD28 (CD28.2) PE-CyTM7.](http://images.novusbio.com/fullsize/CD28-Antibody-CD28-2-Flow-Cytometry-NBP1-79126-img0007.jpg)
![Flow Cytometry: CD28 Antibody (CD28.2) [NBP1-79126] - Separation of human CD28 positive lymphocytes (red-filled) from neutrophil granulocytes (black-dashed) in flow cytometry analysis (surface staining) of human peripheral whole blood stained using anti-human CD28 (CD28.2) purified antibody (concentration in sample 1,6 ug/ml) GAM APC.](http://images.novusbio.com/fullsize/CD28-Antibody-CD28-2-Flow-Cytometry-NBP1-79126-img0008.jpg)
![Immunohistochemistry: Coagulation Factor II/Thrombin Antibody [NBP1-58268] - Analysis of human liver after heat-induced Antigen retrieval. Antibody concentration 5 ug/ml.](http://images.novusbio.com/fullsize/Coagulation-Factor-II-Thrombin-Antibody-Immunohistochemistry-NBP1-58268-img0008.jpg)
![Immunohistochemistry-Paraffin: Coagulation Factor II/Thrombin Antibody [NBP1-58268] - Human Placenta Tissue](http://images.novusbio.com/fullsize/Coagulation-Factor-II-Thrombin-Antibody-Immunohistochemistry-Paraffin-NBP1-58268-img0005.jpg)
![Immunohistochemistry-Paraffin: Coagulation Factor II/Thrombin Antibody [NBP1-58268] - Human Placenta Tissue, 5.0ug/ml.](http://images.novusbio.com/fullsize/Coagulation-Factor-II-Thrombin-Antibody-Immunohistochemistry-Paraffin-NBP1-58268-img0006.jpg)
![Western Blot: Arginase 1/ARG1/liver Arginase Antibody [NBP1-54621] - Jurkat cell lysate, concentration 5.0ug/ml.](http://images.novusbio.com/fullsize/Arginase-1-ARG1-liver-Arginase-Antibody-Western-Blot-NBP1-54621-img0002.jpg "Western Blot: Arginase 1/ARG1/liver Arginase Antibody [NBP1-54621] - Jurkat cell lysate, concentration 5.0ug/ml.")
![Immunohistochemistry-Paraffin: Arginase 1/ARG1/liver Arginase Antibody [NBP1-54621] - Human Lung Alveolar cells (indicated with arrows), 4-8ug/ml.](http://images.novusbio.com/fullsize/Arginase-1-ARG1-liver-Arginase-Antibody-Immunohistochemistry-Paraffin-NBP1-54621-img0003.jpg)
![Immunohistochemistry: Arginase 1/ARG1/liver Arginase Antibody [NBP1-54621] - Genetic deletion of IL-6 results in less fibrosis and increased remodeling at a chronic time point. A) Anti-Arginase 1/ARG1/liver Arginase immunohistochemistry staining results (n = 4-5; ∗P = .0210) and representative slides. The number of Arg1+ cells, a marker for prohealing monocytes and macrophages, was less in the IL-6-/- model. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/35647566/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/nbp1-54621_rabbit-polyclonal-arginase-1-arg1-liver-arginase-antibody-20920231412575.jpg)
![Western Blot: SELENBP1 Antibody [NBP1-54805] - Antibody Titration: 1 ug/ml Human heart.](http://images.novusbio.com/fullsize/SELENBP1-Antibody-Western-Blot-NBP1-54805-img0006.jpg "Western Blot: SELENBP1 Antibody [NBP1-54805] - Antibody Titration: 1 ug/ml Human heart.")
![Immunohistochemistry: SELENBP1 Antibody [NBP1-54805] - Human Adult heart Observed Staining: Cytoplasmic,Membrane (weak) Primary Antibody Concentration: 1 : 600 Secondary Antibody: Donkey anti-Rabbit-Cy2/3 Secondary Antibody Concentration: 1 : 200 Magnification: 20X Exposure Time: 0.5 2.0 sec.](http://images.novusbio.com/fullsize/SELENBP1-Antibody-Immunohistochemistry-NBP1-54805-img0005.jpg)
![Western Blot: SELENBP1 Antibody [NBP1-54805] - Titration: 0.2-1 ug/ml, Positive Control: SH-SYSY cell lysate.](http://images.novusbio.com/fullsize/SELENBP1-Antibody-Western-Blot-NBP1-54805-img0003.jpg)
![Western Blot: SELENBP1 Antibody [NBP1-54805] - Antibody Titration: 1 ug/ml Human liver.](http://images.novusbio.com/fullsize/SELENBP1-Antibody-Western-Blot-NBP1-54805-img0007.jpg)
![Immunohistochemistry-Paraffin: SELENBP1 Antibody [NBP1-54805] - SELENBP1 in colon mucosa (Mouse), dilution 1:500, 10x, 20x and 40x. Image from verfied customer review.](http://images.novusbio.com/fullsize/SELENBP1-Antibody-Immunohistochemistry-Paraffin-NBP1-54805-img0004.jpg)
![Western Blot: VCAM-1/CD106 Antibody (1.G11B1) [NBP1-28404] - Western blot analysis of MDA-MB-231 cells transfected with/without an IL-8 silencer RNA (siIL-8) to evaluate the expression of MUC-1, VCAM-1 (NBP1-28404), and ICAM-1 (NBP2-22541). GAPDH load control was reused for illustrative purposes. Image collected and cropped by CiteAb from the following publication (frontiersin.org/article/10.3389/fimmu.2018.01767/full), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/VCAM-1-CD106-Antibody-1-G11B1-Western-Blot-NBP1-28404-img0007.jpg "<b>Biological Strategies Validation. </b>Western Blot: VCAM-1/CD106 Antibody (1.G11B1) [NBP1-28404] - Western blot analysis of MDA-MB-231 cells transfected with/without an IL-8 silencer RNA (siIL-8) to evaluate the expression of MUC-1, VCAM-1 (NBP1-28404), and ICAM-1 (NBP2-22541). GAPDH load control was reused for illustrative purposes. Image collected and cropped by CiteAb from the following publication (frontiersin.org/article/10.3389/fimmu.2018.01767/full), licensed under a CC-BY license.")
![<b>Biological Strategies Validation. </b>Immunohistochemistry-Paraffin: VCAM-1/CD106 Antibody (1.G11B1) [NBP1-28404] - Veins and venules in the interalveolar stroma of porcine mammary gland are positive for the human VCAM-1. Antigen retrieval by Proteinase K. AlexaFluor 488 anti-mouse antibody was used as a secondary detection antibody. Image from verified customer review.](http://images.novusbio.com/fullsize/VCAM-1-CD106-Antibody-1-G11B1-Immunohistochemistry-Paraffin-NBP1-28404-img0005.jpg)
![Flow Cytometry: VCAM-1/CD106 Antibody (1.G11B1) [NBP1-28404] - TNF alpha stimulated human endothelial cell line HUV-EC-C was stained with Mouse Anti-Human CD106-UNLB followed by Goat Anti-Mouse IgG1, Human ads-FITC.](http://images.novusbio.com/fullsize/VCAM-1-CD106-Antibody-1-G11B1-Flow-Cytometry-NBP1-28404-img0006.jpg)
![Flow Cytometry: VCAM-1/CD106 Antibody (1.G11B1) [NBP1-28404] - Analysis using the FITC conjugate of NBP1-28404. Staining of TNF alpha stimulated endothelial cell line HUV-EC-C.](http://images.novusbio.com/fullsize/VCAM-1-CD106-Antibody-1-G11B1-Flow-Cytometry-NBP1-28404-img0003.jpg)
![Western Blot: VCAM-1/CD106 Antibody (1.G11B1) [NBP1-28404] - Knockdown of RPN2 decreased luminal B BC cell dissemination in vivo. Luminal B ER+ T47D cells, transfected with negative control siRNA (siRNA-C) or siRNA targeting RPN2 (siRNA-RPN2) were injected + estradiol (E2) ± neutrophils (Neu) into zebrafish transgenic embryos with green fluorescent blood vessels & analyzed as described in materials & methods. (A) Migration in vitro (n = 6). (B)In vivo dissemination of transfected T47D in presence of E2 ± Neu (n = 23–26). Scale bar = 100 µm. (n = 23–26). (C) Western blot analysis for confirmation of siRNA-RPN2 transfection & VCAM-1, ICAM-1, & MUC-1 expression. (D) Focal adhesions area (n = 5–6). Scale bar = 10 µm. (E) Proliferation (n = 6). Representative images of zebrafish embryos with disseminated luminal B T47D BC cells & immunocytochemistry analysis of vinculin expression are shown. Arrows show disseminated T47D & arrowheads show focal adhesions. BV = blood vessels. Data are presented as mean ± SEM. Two-tailed Student’s t-test *P < 0.05, ***P < 0.001, ns, not significant. Data are represented of at least two independent experiments. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/33330095), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-28404_mouse-monoclonal-vcam-1-cd106-antibody-1-g11b1-310202416154617.jpg)
![Western Blot: VCAM-1/CD106 Antibody (1.G11B1) [NBP1-28404] - Knockdown of U2AF1 decreased luminal A BC cell dissemination in vivo. Luminal A ER+ MCF-7 cells, transfected with negative control siRNA (siRNA-C) or siRNA targeting U2AF1 (siRNA-U2AF1) were injected in presence of estradiol (E2) ± neutrophils (Neu) into zebrafish transgenic embryos, with green fluorescent blood vessels, & analyzed as described in materials & methods. (A) Migration in vitro (n = 6–12). (B)In vivo dissemination in presence of E2 ± Neu (n = 38–41). Scale bar = 100 µm. (C) Western blot analysis for confirmation of siRNA-U2AF1 transfection & ICAM-1, VCAM-1, & MUC-1 expression. (D) Focal adhesion area (n = 7). Scale bar = 10 µm. (E) Proliferation in vitro (n = 12). Representative images of zebrafish embryos with disseminated MCF-7 cells & immunocytochemistry analysis of vinculin expression are shown. Arrows show disseminated MCF-7 cells & arrowheads show focal adhesions. BV = blood vessels. Data are presented as mean ± SEM. Two-tailed Student’s t-test *P < 0.05, **P < 0.01, ns, not significant. Data are represented of at least two independent experiments. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/33330095), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-28404_mouse-monoclonal-vcam-1-cd106-antibody-1-g11b1-31020241617356.jpg)
![Western Blot: FoxO1/FKHR Antibody (3B6) [NBP2-22190] - Staining in human breast cell lines from nuclear fractions.](http://images.novusbio.com/fullsize/FoxO1-FKHR-Antibody-3B6-Western-Blot-NBP2-22190-img0006.jpg "Western Blot: FoxO1/FKHR Antibody (3B6) [NBP2-22190] - Staining in human breast cell lines from nuclear fractions.")
![Immunocytochemistry/Immunofluorescence: FoxO1/FKHR Antibody (3B6) [NBP2-22190] - Immunofluorescence analysis of Hela cells using FOXO1A mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye.](http://images.novusbio.com/fullsize/FoxO1-FKHR-Antibody-3B6-Immunocytochemistry-Immunofluorescence-NBP2-22190-img0001.jpg)
![Immunohistochemistry-Paraffin: FoxO1/FKHR Antibody (3B6) [NBP2-22190] - Immunohistochemical analysis of paraffin-embedded intima cancer tissues using FOXO1A mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/FoxO1-FKHR-Antibody-3B6-Immunohistochemistry-Paraffin-NBP2-22190-img0002.jpg)
![Western Blot: FoxO1/FKHR Antibody (3B6) [NBP2-22190] - Western blot analysis using FOXO1A mAb against human FOXO1 (AA: 471-600) recombinant protein. (Expected MW is 39.3 kDa)](http://images.novusbio.com/fullsize/FoxO1-FKHR-Antibody-3B6-Western-Blot-NBP2-22190-img0004.jpg)
![Western Blot: FoxO1/FKHR Antibody (3B6) [NBP2-22190] - Western blot analysis using FOXO1A mouse mAb against Hela (1), HEK293 (2), MCF-7(3), and C6 (4) cell lysate.](http://images.novusbio.com/fullsize/FoxO1-FKHR-Antibody-3B6-Western-Blot-NBP2-22190-img0005.jpg)
![ELISA: FoxO1/FKHR Antibody (3B6) [NBP2-22190] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng)](http://images.novusbio.com/fullsize/FoxO1-FKHR-Antibody-3B6-ELISA-NBP2-22190-img0003.jpg)
![Western Blot: FKBP51/FKBP5 Antibody (Hi51B) [NB110-96873] - Blot showing FKBP51/FKBP5 levels in the hippocampus, striatum, ACX, posterior cortex (PCX), interbrain, thalamus and hypothalamus, and cerebellum of a rTgFKBP5 mouse. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30963102/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/FKBP51-FKBP5-Antibody-Hi51B-Western-Blot-NB110-96873-img0007.jpg "Western Blot: FKBP51/FKBP5 Antibody (Hi51B) [NB110-96873] - Blot showing FKBP51/FKBP5 levels in the hippocampus, striatum, ACX, posterior cortex (PCX), interbrain, thalamus and hypothalamus, and cerebellum of a rTgFKBP5 mouse. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30963102/) licensed under a CC-BY license.")
![Immunocytochemistry/Immunofluorescence: FKBP51/FKBP5 Antibody (Hi51B) [NB110-96873] - Immunocytochemistry/Immunofluorescence analysis using Mouse Anti-FKBP51/FKBP5 Monoclonal Antibody, Clone Hi51B (NB110-96873). Tissue: MK cells. Species: Mouse. Primary Antibody: Mouse Anti-FKBP51/FKBP5 Monoclonal Antibody (NB110-96873) at 1:1000. Secondary Antibody: APC Goat Anti-Mouse (red). Counterstain: DAPI (blue) nuclear stain. Cells stained red. Courtesy of: the Hospital Henri Mondor, France.](http://images.novusbio.com/fullsize/FKBP51-FKBP5-Antibody-Hi51B-Immunocytochemistry-Immunofluorescence-NB110-96873-img0006.jpg)
![Western Blot: FKBP51/FKBP5 Antibody (Hi51B) [NB110-96873] - analysis of Human HeLa cell lysates showing detection of FKBP51 protein using Mouse Anti-FKBP51 Monoclonal Antibody, Clone Hi51B . Load: 15 ug protein. Block: 1.5% BSA for 30 minutes at RT. Primary Antibody: Mouse Anti-FKBP51 Monoclonal Antibody at 1:1000 for 2 hours at RT. Secondary Antibody: Sheep Anti-Mouse IgG: HRP for 1 hour at RT.](http://images.novusbio.com/fullsize/FKBP51-FKBP5-Antibody-Hi51B-Western-Blot-NB110-96873-img0005.jpg)
![Western Blot: FKBP51/FKBP5 Antibody (Hi51B) [NB110-96873] - FKBP51/Hsp90 bind to GluR1-type AMPA receptors to regulate trafficking. A, Representative Western blottings form biotinylation assays of receptor endocytosis was performed on ex vivo slices, as described in Materials & Methods, rTgFKBP5 (N = 4; n = 8), WT (N = 2; n = 8), & tTA (N = 2; n = 8). Following labeling with Sulfo-NHS-SS biotin & chemical LTD (20 µM NMDA; 5 min) treatment, receptors were permitted to externalize at 30°C for the indicated times. B, The quantification ± SEM of multiple acquisitions is shown for GluR1. C, Representative Western blottings from anti-GluR1 co-immunoprecipitations & corresponding inputs from control & rTgFKBP5 mice immunoblotted as indicated. rTgFKBP5 (N = 2), WT (N = 2), & tTA (N = 2) total from two independent experiments. D, Representative Western blottings of anti-GluR1 co-immunoprecipitations & corresponding inputs from HEK293T cells transfected with GluR1 & FKBP51 or empty vector (EV) for 48 h were immunoblotted with antibodies as indicated. Just before harvest, cells were treated with 100 µM AMPA or PBS for 10 min to induce GluR1 receptor internalization. *p = 0.0286 by t-test of this time point. **p < 0.001 by two-way ANOVA. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30963102), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb110-96873_mouse-monoclonal-fkbp51-fkbp5-antibody-hi51b-310202416205195.jpg)
![Western Blot: FKBP51/FKBP5 Antibody (Hi51B) [NB110-96873] - Detailed schematic & validation of the FKBP5 TRE transgene. A, To allow for site-directed, single copy insertion into the mouse genome in chromosome 11, the transgenic construct contained flanking attB sites via a PhiC31 integrase. The downstream Mp1 poly A tail will help maintain stable expression. To drive high expression, the transgenic construct included a tetracycline-response element (TRE) promoter made of seven repeats of the tetracycline operators used to drive high expression of the singly inserted FKBP5 gene in the presence of the tTA, & a weak minimal CMV promoter which produces low basal expression. B, Western blotting from HEK293T cells transfected with increasing amounts of FKBP5 TRE plasmid, as indicated, for 48 h. C, HEK293T cells were transfected with the indicated amounts of FKBP5 TRE & tTA plasmid, to ensure the tTA would drive high FKBP51 expression. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30963102), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb110-96873_mouse-monoclonal-fkbp51-fkbp5-antibody-hi51b-310202416203721.jpg)
![Western Blot: FKBP51/FKBP5 Antibody (Hi51B) [NB110-96873] - FKBP51 expression & distribution in rTgFKBP5 mice. A, Expression of human & mouse FKBP5 in rTgFKBP5 mice expressed as fold change ± SEM compared to WT mice using qPCR; ***p < 0.001 by t test (N = 10) with three technical replicates. B, Western blotting showing FKBP51 levels in the hippocampus from rTgFKBP5, WT, FKBP5, & tTA mice. C, Western blotting showing levels of FKBP51 levels in the rTgFKBP5 hippocampus from 1 to 10 µg of protein loaded compared to 50 µg of protein from WT or FKBP51 mice. GAPDH levels are shown to confirm protein load. See Extended Data Figure 2-1 for more information on the antibody. D, 20× images of anti-FKBP51 staining from rTgFKBP5 mice. The entorhinal cortex (ECX), anterior cortex (ACX), CA1, CA3, & dentate gyrus (DG) are labeled. E, 20× images of anti-FKBP51 staining from rTgFKBP5 mice in the CA1, CA3, DG, ECX, & ACX. Scale bar = 100 µm; 10 µm (inset). F, Western blotting showing FKBP51 levels in the hippocampus, striatum, ACX, posterior cortex (PCX), interbrain, thalamus & hypothalamus, & cerebellum of a rTgFKBP5 mouse. G, Quantitation of FKBP51 proteins levels throughout the hippocampus (HPC), striatum (STR), ACX, PCX, interbrain, thalamus & hypothalamus (INTER), & cerebellum (CER), of rTgFKBP5 mice from multiple exposures. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30963102), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb110-96873_mouse-monoclonal-fkbp51-fkbp5-antibody-hi51b-310202416212341.jpg)
![Western Blot: FKBP51/FKBP5 Antibody (Hi51B) [NB110-96873] - FKBP51/Hsp90 bind to GluR1-type AMPA receptors to regulate trafficking. A, Representative Western blottings form biotinylation assays of receptor endocytosis was performed on ex vivo slices, as described in Materials & Methods, rTgFKBP5 (N = 4; n = 8), WT (N = 2; n = 8), & tTA (N = 2; n = 8). Following labeling with Sulfo-NHS-SS biotin & chemical LTD (20 µM NMDA; 5 min) treatment, receptors were permitted to externalize at 30°C for the indicated times. B, The quantification ± SEM of multiple acquisitions is shown for GluR1. C, Representative Western blottings from anti-GluR1 co-immunoprecipitations & corresponding inputs from control & rTgFKBP5 mice immunoblotted as indicated. rTgFKBP5 (N = 2), WT (N = 2), & tTA (N = 2) total from two independent experiments. D, Representative Western blottings of anti-GluR1 co-immunoprecipitations & corresponding inputs from HEK293T cells transfected with GluR1 & FKBP51 or empty vector (EV) for 48 h were immunoblotted with antibodies as indicated. Just before harvest, cells were treated with 100 µM AMPA or PBS for 10 min to induce GluR1 receptor internalization. *p = 0.0286 by t-test of this time point. **p < 0.001 by two-way ANOVA. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30963102), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb110-96873_mouse-monoclonal-fkbp51-fkbp5-antibody-hi51b-310202416212343.jpg)
![Western Blot: FKBP51/FKBP5 Antibody (Hi51B) [NB110-96873] - Detailed schematic & validation of the FKBP5 TRE transgene. A, To allow for site-directed, single copy insertion into the mouse genome in chromosome 11, the transgenic construct contained flanking attB sites via a PhiC31 integrase. The downstream Mp1 poly A tail will help maintain stable expression. To drive high expression, the transgenic construct included a tetracycline-response element (TRE) promoter made of seven repeats of the tetracycline operators used to drive high expression of the singly inserted FKBP5 gene in the presence of the tTA, & a weak minimal CMV promoter which produces low basal expression. B, Western blotting from HEK293T cells transfected with increasing amounts of FKBP5 TRE plasmid, as indicated, for 48 h. C, HEK293T cells were transfected with the indicated amounts of FKBP5 TRE & tTA plasmid, to ensure the tTA would drive high FKBP51 expression. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/30963102), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb110-96873_mouse-monoclonal-fkbp51-fkbp5-antibody-hi51b-310202416212350.jpg)
![Western Blot: ERK1/2 Antibody [NB110-96887] - Western blot analysis of Human Cell line lysates showing detection of ERK1/2 protein using Rabbit Anti-ERK1/2 Polyclonal Antibody (NB110-96887). Load: 15 ugprotein. Block: 1.5% BSA for 30 minutes at RT. Primary Antibody: Rabbit Anti-ERK1/2 Polyclonal Antibody (NB110-96887) at 1:1000 for 2 hours at RT. Secondary Antibody: Donkey Anti-Rabbit IgG: HRP for 1 hour at RT.](http://images.novusbio.com/fullsize/ERK1-2-Antibody-Western-Blot-NB110-96887-img0013.jpg "Western Blot: ERK1/2 Antibody [NB110-96887] - Western blot analysis of Human Cell line lysates showing detection of ERK1/2 protein using Rabbit Anti-ERK1/2 Polyclonal Antibody (NB110-96887). Load: 15 ugprotein. Block: 1.5% BSA for 30 minutes at RT. Primary Antibody: Rabbit Anti-ERK1/2 Polyclonal Antibody (NB110-96887) at 1:1000 for 2 hours at RT. Secondary Antibody: Donkey Anti-Rabbit IgG: HRP for 1 hour at RT.")
![Immunocytochemistry/Immunofluorescence: ERK1/2 Antibody [NB110-96887] - Analysis using Rabbit Anti-ERK1 Polyclonal Antibody. Tissue: HaCaT cells. Species: Human. Fixation: Cold 100% methanol at -20C for 10 minutes. Primary Antibody: Rabbit Anti-ERK1 Polyclonal Antibody at 1:100 for 12 hours at 4 degrees C. Secondary Antibody: FITC Goat Anti-Rabbit at 1:50 for 1-2 hours at RT in dark. Localization: Cytoplasm. Nucleus.](http://images.novusbio.com/fullsize/ERK1-2-Antibody-Immunocytochemistry-Immunofluorescence-NB110-96887-img0011.jpg)
![Immunohistochemistry: ERK1/2 Antibody [NB110-96887] - Immunohistochemistry analysis using Rabbit Anti-ERK1/2 Polyclonal Antibody (NB110-96887). Tissue: backskin. Species: Mouse. Fixation: Bouin's Fixative Solution. Primary Antibody: Rabbit Anti-ERK1/2 Polyclonal Antibody (NB110-96887) at 1:100 for 1 hour at RT. Secondary Antibody: FITC Goat Anti-Rabbit (green) at 1:50 for 1 hour at RT. Localization: Cytoplasm.](http://images.novusbio.com/fullsize/ERK1-2-Antibody-Immunohistochemistry-NB110-96887-img0015.jpg)
![Immunocytochemistry/Immunofluorescence: ERK1/2 Antibody [NB110-96887] - Tissue: HeLa Cells. Species: Human. Fixation: 2% Formaldehyde for 20 min at RT. Primary Antibody: Rabbit Anti-Erk1/2 Polyclonal Antibody at 1:100 for 12 hours at 4 degrees C. Secondary Antibody: APC Goat Anti-Rabbit (red) at 1:200 for 2 hours at RT. Counterstain: DAPI (blue) nuclear stain at 1:40000 for 2 hours at RT. Localization: Cytoplasm. Nucleus. Magnification: 100x. (A) DAPI (blue) nuclear stain. (B) Anti-Erk1/2 Antibody. (C) Composite.Nucleus. Magnification: 100x. (A) DAPI (blue) nuclear stain. (B) Anti-Erk1/2 Antibody. (C) Composite.](http://images.novusbio.com/fullsize/ERK1-2-Antibody-Immunocytochemistry-Immunofluorescence-NB110-96887-img0009.jpg)
![Immunohistochemistry-Paraffin: ERK1/2 Antibody [NB110-96887] - Bouin's fixed paraffin embedded backskin sections of transgenic mice. Courtesy of Dr. Turksen, Ottawa Hospital Research Institute, Canada.](http://images.novusbio.com/fullsize/ERK1-2-Antibody-Immunohistochemistry-Paraffin-NB110-96887-img0003.jpg)
![Immunohistochemistry: ERK1/2 Antibody [NB110-96887] - Immunohistochemistry analysis using Rabbit Anti-ERK1/2 Polyclonal Antibody (NB110-96887). Tissue: Inflamed colon. Species: Mouse. Fixation: Formalin. Primary Antibody: Rabbit Anti-ERK1/2 Polyclonal Antibody (NB110-96887) at 1:25000 for 12 hours at 4C. Secondary Antibody: Biotin Goat Anti-Rabbit at 1:2000 for 1 hour at RT. Counterstain: Methyl Green at 200uL for 2 min at RT. This image was produced using an amplifying IHC wash buffer. The antibody has therefore been diluted more than is recommended for other applications..](http://images.novusbio.com/fullsize/ERK1-2-Antibody-Immunohistochemistry-NB110-96887-img0014.jpg)
![Western Blot: ERK1 Antibody (1E5) [NBP2-22203] - Western blot analysis of whole cell lysates from (1) MCF7 (2) NIH3T3 cell lines using ERK1 antibody (clone 1E5) at 1:1000 dilution. The signal was developed using HRP labeled goat-anti Mouse secondary antibody with ECL based detection.](http://images.novusbio.com/fullsize/ERK1-Antibody-1E5-Western-Blot-NBP2-22203-img0008.jpg "Western Blot: ERK1 Antibody (1E5) [NBP2-22203] - Western blot analysis of whole cell lysates from (1) MCF7 (2) NIH3T3 cell lines using ERK1 antibody (clone 1E5) at 1:1000 dilution. The signal was developed using HRP labeled goat-anti Mouse secondary antibody with ECL based detection.")
![Immunocytochemistry/Immunofluorescence: ERK1 Antibody (1E5) [NBP2-22203] - Analysis of NIH/3T3 cells using ERK1 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.](http://images.novusbio.com/fullsize/ERK1-Antibody-1E5-Immunocytochemistry-Immunofluorescence-NBP2-22203-img0002.jpg)
![Immunohistochemistry-Paraffin: ERK1 Antibody (1E5) [NBP2-22203] - Immunohistochemical analysis of paraffin-embedded breast cancer tissues using ERK1 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/ERK1-Antibody-1E5-Immunohistochemistry-Paraffin-NBP2-22203-img0004.jpg)
![Flow Cytometry: ERK1 Antibody (1E5) [NBP2-22203] - Flow cytometric analysis of Hela cells using ERK1 mouse mAb (blue) and negative control (red).](http://images.novusbio.com/fullsize/ERK1-Antibody-1E5-Flow-Cytometry-NBP2-22203-img0001.jpg)
![Western Blot: ERK1 Antibody (1E5) [NBP2-22203] - Analysis using MAPK3 mAb against human ERK1 (AA: 9-143) recombinant protein. (Expected MW is 40.8 kDa)](http://images.novusbio.com/fullsize/ERK1-Antibody-1E5-Western-Blot-NBP2-22203-img0006.jpg)
![Western Blot: ERK1 Antibody (1E5) [NBP2-22203] - Western blot analysis using ERK1 mouse mAb against Hela (1), Jurkat (2), RAW264.7 (3), HEK293 (4), K562 (5), NIH/3T3 (6), Cos7 (7) and PC-12 (8) cell lysate.](http://images.novusbio.com/fullsize/ERK1-Antibody-1E5-Western-Blot-NBP2-22203-img0007.jpg)
![Immunohistochemistry-Paraffin: ERK1 Antibody (1E5) [NBP2-22203] - Analysis of paraffin-embedded bladder cancer tissues using ERK1 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/ERK1-Antibody-1E5-Immunohistochemistry-Paraffin-NBP2-22203-img0003.jpg)
![ELISA: ERK1 Antibody (1E5) [NBP2-22203] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng)](http://images.novusbio.com/fullsize/ERK1-Antibody-1E5-ELISA-NBP2-22203-img0005.jpg)
![Western Blot: Nav1.7 Antibody (N68/6) [NBP2-12904] - Western Blot analysis of Hamster CHO cells showing detection of Nav1.7 Sodium Channel protein using Mouse Anti-Nav1.7 Sodium Channel Monoclonal Antibody, Clone N68/6 (NBP2-12904). Load: 15 ug. Block: 1.5% BSA for 30 minutes at RT. Primary Antibody: Mouse Anti-Nav1.7 Sodium Channel Monoclonal Antibody (NBP2-12904) at 1:1000 for 2 hours at RT. Secondary Antibody: Sheep Anti-Mouse IgG: HRP for 1 hour at RT.](http://images.novusbio.com/fullsize/Nav1-7-Antibody-N68-6-Western-Blot-NBP2-12904-img0013.jpg "Western Blot: Nav1.7 Antibody (N68/6) [NBP2-12904] - Western Blot analysis of Hamster CHO cells showing detection of Nav1.7 Sodium Channel protein using Mouse Anti-Nav1.7 Sodium Channel Monoclonal Antibody, Clone N68/6 (NBP2-12904). Load: 15 ug. Block: 1.5% BSA for 30 minutes at RT. Primary Antibody: Mouse Anti-Nav1.7 Sodium Channel Monoclonal Antibody (NBP2-12904) at 1:1000 for 2 hours at RT. Secondary Antibody: Sheep Anti-Mouse IgG: HRP for 1 hour at RT.")
![Immunocytochemistry/Immunofluorescence: Nav1.7 Antibody (N68/6) [NBP2-12904] - Immunocytochemistry/Immunofluorescence analysis using Mouse Anti-Nav1.7 Monoclonal Antibody, Clone N68/6 (NBP2-12904). Tissue: Neuroblastoma cells (SH-SY5Y). Species: Human. Fixation: 4% PFA for 15 min. Primary Antibody: Mouse Anti-Nav1.7 Monoclonal Antibody (NBP2-12904) at 1:100 for overnight at 4C with slow rocking. Secondary Antibody: AlexaFluor 488 at 1:1000 for 1 hour at RT. Counterstain: Phalloidin-iFluor 647 (red) F-Actin stain; Hoechst (blue) nuclear stain at 1:800, 1.6mM for 20 min at RT. (A) Hoechst (blue) nuclear stain. (B) Phalloidin-iFluor 647 (red) F-Actin stain. (C) Nav1.7 Antibody (D) Composite.](http://images.novusbio.com/fullsize/Nav1-7-Antibody-N68-6-Immunocytochemistry-Immunofluorescence-NBP2-12904-img0017.jpg)
![Immunohistochemistry: Nav1.7 Antibody (N68/6) [NBP2-12904] - Immunohistochemistry analysis using Mouse Anti-Nav1.7 Sodium Channel Monoclonal Antibody, Clone N68/6 (NBP2-12904). Tissue: backskin. Species: Mouse. Fixation: Bouin's Fixative and paraffin-embedded. Primary Antibody: Mouse Anti-Nav1.7 Sodium Channel Monoclonal Antibody (NBP2-12904) at 1:100 for 1 hour at RT. Secondary Antibody: FITC Goat Anti-Mouse (green) at 1:50 for 1 hour at RT.](http://images.novusbio.com/fullsize/Nav1-7-Antibody-N68-6-Immunohistochemistry-NBP2-12904-img0016.jpg)
![Immunocytochemistry/Immunofluorescence: Nav1.7 Antibody (N68/6) [NBP2-12904] - Human hippocampal sections using this antibody.](http://images.novusbio.com/fullsize/Nav1-7-Antibody-N68-6-Immunocytochemistry-Immunofluorescence-NBP2-12904-img0007.jpg)
![Immunohistochemistry: Nav1.7 Antibody (N68/6) [NBP2-12904] - Immunohistochemistry analysis using Mouse Anti-Nav1.7 Sodium Channel Monoclonal Antibody, Clone N68/6 (NBP2-12904). Tissue: Brain Slice. Species: Mouse. Fixation: Frozen sections. Primary Antibody: Mouse Anti-Nav1.7 Sodium Channel Monoclonal Antibody (NBP2-12904) at 1:1000. Secondary Antibody: HRP/DAB Detection System: Biotinylated Goat Anti-Mouse, Streptavidin Peroxidase, DAB Chromogen (brown). Counterstain: Mayer Hematoxylin (purple/blue) nuclear stain.](http://images.novusbio.com/fullsize/Nav1-7-Antibody-N68-6-Immunohistochemistry-NBP2-12904-img0014.jpg)
![Immunohistochemistry: Nav1.7 Antibody (N68/6) [NBP2-12904] - Immunohistochemistry analysis using Mouse Anti-Nav1.7 Sodium Channel Monoclonal Antibody, Clone N68/6 (NBP2-12904). Tissue: hippocampus. Species: Human. Fixation: Bouin's Fixative and paraffin-embedded. Primary Antibody: Mouse Anti-Nav1.7 Sodium Channel Monoclonal Antibody (NBP2-12904) at 1:1000 for 1 hour at RT. Secondary Antibody: FITC Goat Anti-Mouse (green) at 1:50 for 1 hour at RT.](http://images.novusbio.com/fullsize/Nav1-7-Antibody-N68-6-Immunohistochemistry-NBP2-12904-img0015.jpg)
![Western Blot: ATG3/APG3 Antibody (OTI3H2) - Azide and BSA Free [NBP2-72140] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Apg3 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Apg3.](http://images.novusbio.com/fullsize/ATG3-APG3-Antibody-OTI3H2-Azide-and-BSA-Free-Western-Blot-NBP2-72140-img0002.jpg "Western Blot: ATG3/APG3 Antibody (OTI3H2) - Azide and BSA Free [NBP2-72140] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Apg3 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Apg3.")
![Immunocytochemistry/Immunofluorescence: ATG3/APG3 Antibody (OTI3H2) - Azide and BSA Free [NBP2-72140] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY Apg3.](http://images.novusbio.com/fullsize/ATG3-APG3-Antibody-OTI3H2-Azide-and-BSA-Free-Immunocytochemistry-Immunofluorescence-NBP2-72140-img0004.jpg)
![Immunohistochemistry: ATG3/APG3 Antibody (OTI3H2) - Azide and BSA Free [NBP2-72140] - Staining of paraffin-embedded Human Kidney tissue using anti-Apg3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ATG3-APG3-Antibody-OTI3H2-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72140-img0008.jpg)
![Flow Cytometry: ATG3/APG3 Antibody (OTI3H2) - Azide and BSA Free [NBP2-72140] - Analysis of Hela cells, using anti-Apg3 antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/ATG3-APG3-Antibody-OTI3H2-Azide-and-BSA-Free-Flow-Cytometry-NBP2-72140-img0003.jpg)
![Western Blot: ATG3/APG3 Antibody (OTI3H2) - Azide and BSA Free [NBP2-72140] - Analysis of extracts (35ug) from 9 different cell lines by using anti-Apg3 monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).](http://images.novusbio.com/fullsize/ATG3-APG3-Antibody-OTI3H2-Azide-and-BSA-Free-Western-Blot-NBP2-72140-img0001.jpg)
![Immunohistochemistry: ATG3/APG3 Antibody (OTI3H2) - Azide and BSA Free [NBP2-72140] - Staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-Apg3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ATG3-APG3-Antibody-OTI3H2-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72140-img0005.jpg)
![Immunohistochemistry: ATG3/APG3 Antibody (OTI3H2) - Azide and BSA Free [NBP2-72140] - Staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-Apg3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ATG3-APG3-Antibody-OTI3H2-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72140-img0006.jpg)
![Immunohistochemistry: ATG3/APG3 Antibody (OTI3H2) - Azide and BSA Free [NBP2-72140] - Staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-Apg3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ATG3-APG3-Antibody-OTI3H2-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72140-img0007.jpg)
![Immunohistochemistry: ATG3/APG3 Antibody (OTI3H2) - Azide and BSA Free [NBP2-72140] - Staining of paraffin-embedded Human tonsil using anti-Apg3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ATG3-APG3-Antibody-OTI3H2-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72140-img0009.jpg)
![Western Blot: HSP70/HSPA1A Antibody (OTI3G9) - Azide and BSA Free [NBP2-70954] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY HSPA1A (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-HSPA1A.(1:500)](http://images.novusbio.com/fullsize/HSP70-HSPA1A-Antibody-OTI3G9-Azide-and-BSA-Free-Western-Blot-NBP2-70954-img0002.jpg "Western Blot: HSP70/HSPA1A Antibody (OTI3G9) - Azide and BSA Free [NBP2-70954] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY HSPA1A (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-HSPA1A.(1:500)")
![Immunocytochemistry/Immunofluorescence: HSP70/HSPA1A Antibody (OTI3G9) - Azide and BSA Free [NBP2-70954] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY Hsp70.](http://images.novusbio.com/fullsize/HSP70-HSPA1A-Antibody-OTI3G9-Azide-and-BSA-Free-Immunocytochemistry-Immunofluorescence-NBP2-70954-img0004.jpg)
![Immunohistochemistry: HSP70/HSPA1A Antibody (OTI3G9) - Azide and BSA Free [NBP2-70954] - Staining of paraffin-embedded pancreas tissue using anti-Hsp70 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/HSP70-HSPA1A-Antibody-OTI3G9-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70954-img0009.jpg)
![Flow Cytometry: HSP70/HSPA1A Antibody (OTI3G9) - Azide and BSA Free [NBP2-70954] - Analysis of permeabilized Jurkat cells, using anti-HSPA1A antibody( Red), compared to an isotype control (green), and a PBS control (blue).(1:100)](http://images.novusbio.com/fullsize/HSP70-HSPA1A-Antibody-OTI3G9-Azide-and-BSA-Free-Flow-Cytometry-NBP2-70954-img0003.jpg)
![Western Blot: HSP70/HSPA1A Antibody (OTI3G9) - Azide and BSA Free [NBP2-70954] - Analysis of extracts (35ug) from 9 different cell lines by using anti-Hsp70 monoclonal antibody.](http://images.novusbio.com/fullsize/HSP70-HSPA1A-Antibody-OTI3G9-Azide-and-BSA-Free-Western-Blot-NBP2-70954-img0001.jpg)
![Immunohistochemistry: HSP70/HSPA1A Antibody (OTI3G9) - Azide and BSA Free [NBP2-70954] - Staining of paraffin-embedded Adenocarcinoma of ovary tissue using anti-Hsp70 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/HSP70-HSPA1A-Antibody-OTI3G9-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70954-img0005.jpg)
![Immunohistochemistry: HSP70/HSPA1A Antibody (OTI3G9) - Azide and BSA Free [NBP2-70954] - Staining of paraffin-embedded endometrium tissue using anti-Hsp70 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/HSP70-HSPA1A-Antibody-OTI3G9-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70954-img0006.jpg)
![Immunohistochemistry: HSP70/HSPA1A Antibody (OTI3G9) - Azide and BSA Free [NBP2-70954] - Staining of paraffin-embedded Kidney tissue using anti-Hsp70 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/HSP70-HSPA1A-Antibody-OTI3G9-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70954-img0007.jpg)
![Immunohistochemistry: HSP70/HSPA1A Antibody (OTI3G9) - Azide and BSA Free [NBP2-70954] - Staining of paraffin-embedded liver tissue using anti-Hsp70 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/HSP70-HSPA1A-Antibody-OTI3G9-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70954-img0008.jpg)
![Immunohistochemistry: HSP70/HSPA1A Antibody (OTI3G9) - Azide and BSA Free [NBP2-70954] - Staining of paraffin-embedded prostate tissue using anti-Hsp70 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/HSP70-HSPA1A-Antibody-OTI3G9-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70954-img0010.jpg)